To distinguish PDGFRα and PDGFRβ signalling in TAM recruitment, anti-mouse PDGFRα- and PDGFRβ-specific neutralizing antibodies (PDGFR blockades) were used for the treatment of PDGF-BB+ T241 tumours. The gene discussed is PDGFRA; the disease is neoplasm.